Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

August 31, 2012

Study Completion Date

February 28, 2013

Conditions
Lung Cancer
Interventions
PROCEDURE

Computed Tomography-Guided Optical Sensor-Guided Radiofrequency Ablation

Undergo RFA

Trial Locations (17)

35294

UAB Comprehensive Cancer Center, Birmingham

37404

H. Clay Evans Johnson Cancer Center at Memorial Hospital, Chattanooga

45220

Good Samaritan Hospital Cancer Treatment Center, Cincinnati

48073

William Beaumont Hospital - Royal Oak Campus, Royal Oak

53226

Medical College of Wisconsin Cancer Center, Milwaukee

75230

Medical City Dallas Hospital, Dallas

84112

Huntsman Cancer Institute at University of Utah, Salt Lake City

95817

University of California Davis Cancer Center, Sacramento

99204

Providence Cancer Center at Sacred Heart Medical Center, Spokane

99207

Providence Cancer Center at Holy Family Hospital, Spokane

90095-1781

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

02114

Massachusetts General Hospital, Boston

02118

Boston University Cancer Research Center, Boston

11794-9446

Stony Brook University Cancer Center, Stony Brook

27599-7295

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

97213-2967

Providence Cancer Center at Providence Portland Medical Center, Portland

02903

Rhode Island Hospital Comprehensive Cancer Center, Providence

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00109876 - Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter